Saturday 17 October 2026 Export NAGE’s income statement to Excel — free account

Niagen Bioscience, Inc.

Niagen Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.4 million, up 29.9% from fiscal 2024. In the quarter to June 2026, revenue fell 4.28%, EPS fell 80.0% and free cash flow grew 140.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

2.49 0.09 −3.49%

Follow NAGE

Alert me

Market cap: $204.2M
P/E: 12.5×
Fwd P/E: 15.0×
Dividend yield: —
F-score: 6/9
Altman Z: 10.54
Beneish M: −1.55
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	34.56	27.65	18.38	15.95
P/S ratio Full definition →		5.97	3.89	2.70	1.96
P/FCF ratio Full definition →		35.23	38.17	35.64	22.09
P/Operating CF Full definition →		201.61	741.64	(295.17)	91.28
P/B ratio Full definition →		10.53	6.58	4.28	3.07
Price to Tangible BV Full definition →		10.57	7.11	4.59	3.28
EV/Sales Full definition →		5.47	3.40	2.21	1.46
EV/EBITDA Full definition →		33.96	25.82	20.61	16.26
EV/Operating CF Full definition →		31.85	32.63	65.00	31.63
EV/FCF Full definition →		32.27	33.40	29.10	16.43
Quick Ratio Full definition →		3.21	3.74	3.49	5.00
Current Ratio Full definition →		4.12	4.86	4.61	6.50
Net Debt/EBITDA Full definition →		(14.51)	(15.12)	(35.64)	(67.35)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		1.61	1.48	1.33	1.30
Operating CF/Net income Full definition →		0.81	0.16	(0.19)	2.88
Capex/Depreciation Full definition →		(0.12)	(0.51)	19.72	(0.31)
Research and Development Expense of Revenue Full definition →		5.28%	5.05%	4.71%	5.08%
Selling, General and Administrative Expense of Revenue Full definition →		46.78%	52.87%	53.76%	57.41%
Intangible Assets out of Total Assets Full definition →		0.00	0.05	0.05	0.05
Share Based Compensation of Revenue Full definition →		5.17%	5.17%	5.45%	5.78%
Graham Net Nets Full definition →		0.09	0.13	0.21	0.29
Graham Number Full definition →		2.32	2.24	2.36	2.16
Earnings Yield Full definition →		2.89%	3.62%	5.44%	6.27%
Free Cash Flow Yield Full definition →		2.84%	2.62%	2.81%	4.53%
Revenue per Share Full definition →		0.43	0.43	0.39	0.38
Operating CF per Share Full definition →		0.05	0.01	(0.01)	0.03
Capex per Share Full definition →		0.00	0.00	0.07	0.00
Free Cash Flow per Share Full definition →		0.05	0.01	0.06	0.03
Cash per Share Full definition →		0.81	0.82	0.83	0.84
Shareholders Equity per Share Full definition →		0.89	0.97	1.03	1.04
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.89	0.97	1.03	1.04
Free Cash Flow Full definition →		3.67	0.58	4.55	2.68
Working Capital Full definition →		70.90	76.89	82.30	82.74
Capital Expenditures Full definition →		(0.02)	(0.10)	5.74	(0.09)
Net Current Asset Value Full definition →		66.15	66.93	73.12	73.73
EV/EBIT Full definition →		35.33	27.07	21.99	17.75
Capex to Sales Full definition →		0.00	0.00	(0.18)	0.00
Price to Operating Income Full definition →		38.56	30.93	26.94	23.88
Other line items
Average Receivables Full definition →		7.80	8.75	10.06	9.12
Average Payables Full definition →		9.82	9.66	11.95	11.56
Average Inventory Full definition →		14.67	14.81	17.60	17.52
Average Assets Full definition →		77.33	87.34	97.83	99.06
Average Common Equity Full definition →		52.52	61.31	68.84	73.36

Show all line items

Columns are period end dates

Stockrow Weekly